Literature DB >> 3603547

HLA and leprosy in Koreans.

S J Kim, I H Choi, S Dahlberg, B Nisperos, J D Kim, J A Hansen.   

Abstract

HLA antigens in 157 unrelated Koreans with leprosy have been identified and compared with 162 healthy Korean controls. The patient group consisted of 124 with lepromatous leprosy and 33 with tuberculoid leprosy. Although no significant differences were detected between the two patient groups, several antigens were found to be increased in the combined patient group compared to healthy controls. Two Class I antigens were increased: HLA-A11 (22% vs 12%) and Aw33 (27% vs 14%). Four Class II antigens were increased: HLA-DR1 (16% vs 7%), DR2 (39% vs 21%), DRw9 (14% vs 6%) and DQw1 (74% vs 55%). HLA-DR4 (28% vs 48%), DRw53 (46% vs 69%) and DQw3 (50% vs 75%) in contrast were significantly decreased in patients. Interaction of DR1, DR2, DRw9 and DQw1 as risk factors was analyzed. HLA-DR2 appeared to be the strongest risk factor. No evidence for synergy between DR1, DR2 and DRw9 was detected. DQw1 was not significantly increased in patients in the absence of DR1 and DR2, and thus it was not apparent in this study that DQw1 was an independent risk factor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3603547     DOI: 10.1111/j.1399-0039.1987.tb01567.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  10 in total

Review 1.  HLA and disease.

Authors:  Yogita Ghodke; Kalpana Joshi; Arvind Chopra; Bhushan Patwardhan
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 2.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

3.  HLA-DR and HLA-DQ alleles in patients from the south of Brazil: markers for leprosy susceptibility and resistance.

Authors:  Samira A da Silva; Priscila S Mazini; Pâmela G Reis; Ana M Sell; Luiza T Tsuneto; Paulo R Peixoto; Jeane E L Visentainer
Journal:  BMC Infect Dis       Date:  2009-08-22       Impact factor: 3.090

4.  Serological responses of patients with lepromatous and tuberculoid leprosy to 30-, 31-, and 32-kilodalton antigens of Mycobacterium tuberculosis.

Authors:  H S Rumschlag; T M Shinnick; M L Cohen
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

5.  T-cell recognition of mycobacterial GroES peptides in Thai leprosy patients and contacts.

Authors:  B Chua-Intra; S Peerapakorn; N Davey; S Jurcevic; M Busson; H M Vordermeier; C Pirayavaraporn; J Ivanyi
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

6.  Vitamin D Receptor Gene TaqI, BsmI and FokI Polymorphisms in Korean Patients with Tuberculosis.

Authors:  Tae Jin Kang; Song Hou Jin; Chung-Eun Yeum; Seong Beom Lee; Chi Hong Kim; Sang Haak Lee; Kwan Hyoung Kim; Eun-Soon Shin; Gue-Tae Chae
Journal:  Immune Netw       Date:  2011-10-31       Impact factor: 6.303

Review 7.  Role of HLA, KIR, MICA, and cytokines genes in leprosy.

Authors:  Luciana Ribeiro Jarduli; Ana Maria Sell; Pâmela Guimarães Reis; Emília Ângela Sippert; Christiane Maria Ayo; Priscila Saamara Mazini; Hugo Vicentin Alves; Jorge Juarez Vieira Teixeira; Jeane Eliete Laguila Visentainer
Journal:  Biomed Res Int       Date:  2013-07-08       Impact factor: 3.411

8.  Human leukocyte antigen class I and class II alleles are associated with susceptibility and resistance in borderline leprosy patients from Southeast Brazil.

Authors:  Fabiana Covolo de Souza-Santana; Elaine Valim Camarinha Marcos; Maria Esther Salles Nogueira; Somei Ura; Jane Tomimori
Journal:  BMC Infect Dis       Date:  2015-01-21       Impact factor: 3.090

9.  Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy.

Authors:  L Zerva; B Cizman; N K Mehra; S K Alahari; R Murali; C M Zmijewski; M Kamoun; D S Monos
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  Novel HLA Class I Alleles Associated with Indian Leprosy Patients.

Authors:  U. Shankarkumar; K. Ghosh; S. Badakere; D. Mohanty
Journal:  J Biomed Biotechnol       Date:  2003
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.